Floatz logo

coq10

Brain Astrocytoma

Seema NagpalSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Brain Astrocytoma cohort.

Asset / SponsorPhaseRating
Intranasal Modified Temozolomide
Center Trials & Treatment Europe
Phase 1CC
Lomustine
Jasper Gerritsen
D
Triapine
National Cancer Institute (NCI)
Phase 1NR

Same molecule, other indications

coq10 is also rated in:

Huntington diseaseDormant
B
Indicative ·
62 / 100
View asset →
Duchenne muscular dystrophyDormant
B
Indicative ·
62 / 100
View asset →
Becker muscular dystrophyDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →